PATENT CLAIM ANALYSIS

Application Number: 16380513
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["705", "002000"]

Abstract:
Measurement of circulating ST2 and natriuretic peptide (e.g., NT-proBNP) concentrations is useful for the prognostic evaluation of subjects, in particular for the prediction of adverse clinical outcomes, e.g., mortality, transplantation, and heart failure.

Claim (Index 10):
The method of  claim 1 , wherein the subject has a BMI of 25-29, a BMI of \u226530, or renal insufficiency.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 100.0
- Lexical Diversity: 1.35484
- Patent Class: 705.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15385095', '11789169', '13422574', '13787975', '15410155']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.0963391073641045
- 35 USC 102 Novelty (BERT): 0.5858128365779101
- Combined Prediction Score: 0.145286480285485
- Mean Citation Score: 292.468044
- Max Citation Score: 472.3801
- Similarity Product: 446.15707726401087

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test